AbstractThe objective of this work is to analyze the survival of infliximab,
etanercept and adalimumab in patients who have switched among tumor necrosis
factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a
national registry of patients with different forms of chronic arthritis who are
treated with biologics. Using this registry, we have analyzed patient switching
of TN... hiện toàn bộ